GBI Research forecasts $2.3B solid tumor market
November 2013
SHARING OPTIONS:

NEW YORK—GBI Research notes in its latest report, “Solid Tumors Market in Asia Pacific to 2019: New Drug Approvals and Anticipated Product Launches to Trigger a Shift in Treatment Paradigm to Targeted Therapies,” that the Asia-Pacific solid tumor treatment markets—specifically ovarian, prostate, bladder and pancreatic cancers—are expected to grow at a CAGR of 12.3 percent, reaching $2.3 billion in 2019. The market reached $1 billion in 2012. The report names Australia as the fastest-growing market for solid tumors in the region, with a CAGR of 13.9 percent. India is expected to see a CAGR of 9.7 percent, with China’s market growing at a rate of 5.5 percent. Average treatment costs for these cancers are expected to increase as well, growing by 6.5 percent from $4,001 in 2012 to $6,212 by 2019.

Back
 
CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.